You are here

Treanda

Additional exclusivity for a cancer treatment could cost the public $3 billion, analyst says

Endpoints

Mon, 02/25/19 - 11:32 pm

Eagle Pharmaceuticals

Eagle Receives Orphan Drug Designation for Bendeka

CP Wire

Mon, 07/9/18 - 10:52 am

Eagle Pharmaceuticals

Eagle Receives Orphan Drug Designation for Bendeka

Mon, 07/9/18 - 09:32 am

Eagle Pharmaceuticals

Two cancer drug prices have already been hiked by 8% this year

Marketwatch

Wed, 07/5/17 - 09:35 am

Teva Pharmaceutical

9 Drugs That Cost Medicare a Fortune

Motley Fool

Sun, 04/10/16 - 01:29 pm

Teva announces additional regulatory exclusivity for TREANDA

The Fly on the Wall

Wed, 11/27/13 - 08:41 am

indolent non-Hodgkin's lymphoma

Study of Treanda shows great promise for Teva's drug

Fierce Pharma

Mon, 06/4/12 - 05:46 pm

Teva Pharmaceuticals

non-Hodgkin's lymphoma

Teva’s Treanda Delays Tumor Growth

BusinessWeek

Sun, 06/3/12 - 01:46 pm

Teva Pharmaceuticals

mantle cell lymphoma

Teva Recalls 1 Batch Of Treanda Due To Presence Of Glass In Vial

Fox Business

Sat, 01/28/12 - 12:44 pm

Teva Pharmaceuticals

Feds Probe Cephalon For Off-Label Treanda Promotion

Pharmalot

Mon, 07/11/11 - 12:22 pm

chronic lymphocytic leukemia

Cephalon’s Treanda Poised for 10-Fold Sales Surge

Bloomberg

Mon, 12/7/09 - 11:33 am

Following patient death, Cephalon warns of using Treanda with allopurinol

Bizjournals.com

Tue, 04/28/09 - 04:10 pm

Cephalon Inc. Struggles with Staunch Technical Resistance

Schaeffers Resarch

Fri, 02/13/09 - 11:59 am